Back to today’s briefing

Story perspectives

Asterix Foods Secures $4.2M to Revolutionize Protein Production

10/9/2025

50 5

Summary

Story summary

Asterix Foods, Tel Aviv-based, raised $4.2 million in Seed funding led by CPT Capital to advance alternative protein production.
It uses plant cell suspension cultures in Massively Parallel Modular Bioreactors (MPMB), cutting costs by over 95% versus traditional precision fermentation.
Founded in 2022, Asterix seeks corporates for proteins critical to future supply chains; the team includes eight Ph.D. researchers.

1 of 1

Story summary

Asterix Foods, Tel Aviv-based, raised $4.2 million in Seed funding led by CPT Capital to advance alternative protein production.
It uses plant cell suspension cultures in Massively Parallel Modular Bioreactors (MPMB), cutting costs by over 95% versus traditional precision fermentation.
Founded in 2022, Asterix seeks corporates for proteins critical to future supply chains; the team includes eight Ph.D. researchers.